Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996097 · ClinicalTrials.gov registry record · NA
Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02996097: Completed NA study, sponsored by Johns Hopkins University.
NCT02996097 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02996097, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.
Interventions
- DEVICE The Lutronic electronic carbon dioxide (eCO2) Plus laser system
- DRUG Intralesional Triamcinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02996097
The ClinicalTrials.gov registry entry for NCT02996097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which The Lutronic electronic carbon dioxide (eCO2) Plus laser system is the first listed.
NCT02996097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02996097 about?
NCT02996097 is a clinical study titled "Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids". The purpose of this study is to compare the effects of fractional carbon dioxide (CO2) laser therapy immediately followed by intralesional steroid therapy against intralesional steroid therapy alone for the treatment of keloids.
What is the current status of trial NCT02996097?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-04. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT02996097?
The interventions under investigation include: The Lutronic electronic carbon dioxide (eCO2) Plus laser system (DEVICE), Intralesional Triamcinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT02996097?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.